Centre has placed order for 11.45 Crore Hydroxychloroquine tablets. This drug is obtained by HLL lifecare, on behalf of Union Health Ministry.
The Hydroxychloroquine drug is being used to treat Coronavirus although this drug does not cure the patient from the virus. The drug can be only used under medical supervision. Hydroxychloroquine is an anti-malarial drug and is recommended by National Task Force for frontline health care workers and has been approved by Drug Controller General Of India.
The medication is not recommended for children below 12 years and pregnant mothers. The drug has many side effects and if taken without medical supervision can cause serious damage in human body.
According to officials, “out of 6.64 Crore Hydroxychloroquine drugs, the Centre has distributed at least 4.3 Crore Hydroxychloroquine tablets to the states and the remaining is kept in Centre State buffer stock”.
A senior official at health ministry said ANI, “For Hydroxychloroquine, we have ordered for about 11.45 Crore tablets to two Indian firms- IPCA laboratories and Zydus Cadila. So far we have received 6.64 Crore HCQ drugs and remaining will arrive by May 16”.
The Hydroxychloroquine drug has been exported to 87 Coronavirus hit countries. There was steep rise in demand of the anti malarial drug, as India is the sole exporter of the drug. India has exported nearly 50 Million tablets to US alone. India manufacturers 70% of the world’s supply of Hydroxychloroquine.
Media publication MDedge on Friday reported that Hydroxychloroquine is the first line therapy for treating Covid-19 positive patients. The drug has been effective in initial phases of person affected by the virus, but the drug possess a lot of danger and side effects. India’s National Task Force for Covid-19 issued a statement earlier saying, ” the use of drug should be under medical supervision and exceptional condition”.